Cancer Diagnostics

VDI’s portfolio of cancer blood tests gives you more tools for diagnosing and monitoring cancer in your patients. Available for Dogs, Cats, and Horses.

Cancer in companion animals

One in three dogs will be diagnosed with cancer in their lifetime and sadly 50% of those will die from cancer. Cats are prone to develop GI Lymphoma at an alarming rate. Fortunately, advances in therapies, procedures, and medications have given veterinarians more options to help treat and manage cancer in their patients. Being able to offer those options to their clients often requires earlier, affordable detection and ways to monitor the outcome of therapy.


VDI Blood Tests

Hand holding a blood test tube.

VDI Laboratory is a leader in blood tests for the diagnosis and monitoring of cancer in companion animals. Let’s explore how VDI’s technology gives you an advantage for managing this deadly disease in your patients.

Canine Cancer

Blood tests for the detection and management of suspected cancer


Canine Cancer Panel

The Canine Cancer panel is dual-marker blood test for diagnosing and managing cancer in a variety of tumor types in dogs. Commonly used as a first-step diagnosis prior to, or in place of biopsy, the cancer panel can give you confidence that neoplasia is present, and if proceeding to more invasive costly workup or referral to specialists is warranted. After diagnosis is made, the Cancer Panel can be used to monitor disease progression or therapy outcomes.

Common Applications:

  • Lymphoma
  • Abdominal mass
  • Solid tumors
  • Mast Cell Tumors (stage II)
  • ADR dog
  • Hypercalcemia of malignancy
  • Chemotherapy management
  • Post mass-removal confirmation
  • Metastatic Disease

Not recommended for:

  • Cutaneous masses
  • Mast Cell Tumors (stage I)
  • Brain tumors

Reports Include:

  • TK1 result
  • C-Reactive Protein result
  • Neoplasia Index (NI)
  • Interpretive Comments
  • Contextual Review (must provide context on requisition form)

Sample Reports:


Pericardial Effusion Panel

The Canine Pericardial Effusion Panel uses TK1 from serum and pericardial fluid to determine if the source of the effusion is due to cancer. Neoplastic causes of PCE, particularly hemangiosarcoma, impart a significantly worse prognosis than non-neoplastic etiologies. Ratio of TK1 serum to pericardial fluid is able to rule-out cancer effectively. Contact VDI for more information on the Pericardial Effusion Panel.

Feline Cancer

Blood tests for the detection and management of suspected cancer

Feline GI Lymphoma Panel

The Feline GI Lymphoma Panel is a 4-marker panel used for the diagnosis of Feline GI LSA in the acutely ill cat. Cats are notorious for GI inflammatory disease, and it continues to be one of the harder determinations we see. As GI disease progresses if often times overlaps with the development of Lymphoma – making the differential determination challenging using ultrasound alone. Reluctance and inability to biopsy leaves diagnosis a guess. The Feline GI LSA panel takes the guesswork out.

Applications:

  • GI Lymphoma
  • Chronic progressive IBD
  • ADR cat
  • Chemotherapy management

Reports Include:

  • TK1 result
  • HPT result
  • B12/ Folate results
  • B12 dosing guidelines
  • Neoplasia Index (NI) f.GILSA
  • Interpretive Comments
  • Contextual Review (must provide context on requisition form)

Sample Reports:


Feline Cancer Panel

The Feline Cancer panel is dual-marker blood test for diagnosing and managing cancer in cats – typically used for non GI related cancers, as the Feline GI Lymphoma Panel is the better option in those cases. The Feline Cancer Panel is used as a first-step diagnosis prior to, or in place of biopsy, and can give you confidence that neoplasia is present. It’s also used to decide ff proceeding to more invasive costly workup or referral to specialists is warranted. After diagnosis is made, the Feline Cancer Panel can be used to monitor disease progression or therapy outcomes.

Applications:

  • Solid Tumors
  • ADR Cat
  • Can be used for GI Lymphoma

Reports Include:

  • TK1 result
  • HPT result
  • Neoplasia Index (NI)
  • Interpretive Comments
  • Contextual Review (must provide context on requisition form)

Sample Reports:

Equine Lymphoma

Thymidine Kinase Type 1 – Equine Lymphoma Test

Thymidine Kinase Type 1 (TK1) is a DNA proliferation marker that has been shown in a number of human and animal studies to be highly elevated in Lymphoma. High cellular turnover, especially in aggressive & poorly differentiated lymphoma, gives lymphoma a robust TK1 response that is readily picked up in blood serum. Measurement of TK1 activity can be a rule-in for lymphoma in the suspected horse.